Skip to main content

Table 3 Prevalence of MetS by definition

From: Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa—a systematic review and meta-analysis

  Author and publication year HIV status Prevalence by definition criteria
HIV+ HIV− IDF ATP Others
1 Amusa et al., 2016 [33] 150 50 NA NA 41 (27.3%), P < 0.01Ϯ
2 (4%), P < 0.01α—not stated
2 Ayodele et al., 2012 [32] 291 NA 50 (17.2%) 37 (12.7%) 61(21.0%)—JIS
3 Berhane et al., 2012 [34] 313 NA NA 66 (21.1%) NA
4 Tesfaye et al., 2014 [42] 374 NA 23.8% 16.8% NA
5 Sobieszczyk et al., 2016 [29] 160 NA NA 27 (8.7%) NA
6 Obirikorang et al., 2016 [41] 433 NA 183 (42.3%) 209 (48.3%) 106 (24.5%)—WHO
7 Ngatchou et al., 2013 [40] 108 96 47.0%, P = 0.02Ϯ
21.0%, P = 0.02α
NA NA
8 Fourie et al., 2010 [35] 300 300 21.1%, P = 0.65Ϯ
22.6%, P = 0.65α
15.2% P = 0.18Ϯ
11.5% P = 0.18α
NA
9 Muhammad et al., 2013 [45] 200 NA ART = 21.0%;
Naive = 9.0%
P = 0.017
NA NA
10 Mbunkah et al., 2014 [38] 173 50 NA 15.6% (27/173) (P = 0.020)Ϯ
8.0% (4/50)α
NA
11 Guehi et al., 2016 [30] 755 NA NA 47 (6.2%) P > 0.0001 NA
12 Mashinya et al., 2015 [37] 214 NA NA 20 (9.6%) P = 0.56 NA
13 Guira et al., 2016 [31] 300 NA 54 (18.0%) NA NA
14 Hirigo et al., 2016 [36] 185 NA 24.3% (45/185) 17.8% NA
15 Zannou et al., 2009 [28] 79 NA 10 (12.7%) NA NA
16 Muyanja et al., 2016 [39] 250 NA NA 145/250 (58.0%) P value = 0.10 NA
  1. ,NA not applicable
  2. αHIV-negative
  3. ϮHIV-positive